| Amount | Holding | 
|---|---|
| 2.86% | Roche Holding AG Dividend Right Cert. | 
| 2.33% | Nestle SA | 
| 1.66% | Novartis AG | 
| 1.49% | Schneider Electric SE | 
| 1.42% | AstraZeneca PLC ADR | 
| 1.35% | CSL Ltd | 
| 1.34% | Eiffage SA | 
| 1.25% | GlaxoSmithKline PLC | 
| 1.23% | Allianz SE | 
| 1.22% | Novo Nordisk A/S B | 
Expense Ratio Rating
1 /10
Expense Rating
0 /10
Market Score
3 /10
Category Score
10 /10
Market Size
3 /10
Nationwide Bailard International Equities Fund Class C
Expenses: 2.01% (Better than 0% of similar funds)
This is a bad choice for a Large Blend International Stocks fund. See why ยป
| Amount | Holding | 
|---|---|
| 2.86% | Roche Holding AG Dividend Right Cert. | 
| 2.33% | Nestle SA | 
| 1.66% | Novartis AG | 
| 1.49% | Schneider Electric SE | 
| 1.42% | AstraZeneca PLC ADR | 
| 1.35% | CSL Ltd | 
| 1.34% | Eiffage SA | 
| 1.25% | GlaxoSmithKline PLC | 
| 1.23% | Allianz SE | 
| 1.22% | Novo Nordisk A/S B | 
Minafi - The intersection of FI, minimalism & mindfulness.
Don't miss out on new posts, courses, interactive articles and more!
Join & Get Your First Course Free© 2025 Adam Fortuna
Site Map